{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:17:37Z","timestamp":1790637457580,"version":"4.1.0"},"reference-count":75,"publisher":"Wiley","issue":"5","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd010610","type":"journal-article","created":{"date-parts":[[2013,6,24]],"date-time":"2013-06-24T17:59:50Z","timestamp":1372096790000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Topiramate for the prophylaxis of episodic migraine in adults"],"prefix":"10.1002","volume":"2016","author":[{"given":"Mattias","family":"Linde","sequence":"first","affiliation":[{"name":"Norwegian University of Science and Technology; Department of Neuroscience; Trondheim Norway"},{"name":"St. Olav\u2019s University Hospital; Norwegian Advisory Unit on Headaches; Trondheim Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim M","family":"Mulleners","sequence":"additional","affiliation":[{"name":"Canisius Wilhelmina Ziekenhuis; Department of Neurology; PO Box 9015 Nijmegen Netherlands 6500 GS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward P","family":"Chronicle","sequence":"additional","affiliation":[{"name":"University of Hawaii at Manoa; (Deceased) Department of Psychology; Manoa USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas C","family":"McCrory","sequence":"additional","affiliation":[{"name":"Duke University Medical Center; Department of Medicine; Durham NC USA 27710"},{"name":"Durham Veterans Affairs Medical Center; Center for Health Services Research in Primary Care; 508 Fulton St Durham NC USA 27705"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,6,24]]},"reference":[{"issue":"2","key":"10.1002\/14651858.CD010610-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3109\/00207454.2011.626908","article-title":"A comparative study of the effects of low-dose topiramate versus sodium valproate in migraine prophylaxis","volume":"122","author":"Afshari","year":"2012","journal-title":"International Journal of Neuroscience"},{"issue":"5","key":"10.1002\/14651858.CD010610-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1600-0404.2008.01087.x","article-title":"A double-blind, randomized trial of low-dose topiramate vs propranolol in migraine prophylaxis","volume":"118","author":"Ashtari","year":"2008","journal-title":"Acta Neurologica Scandinavica"},{"issue":"10","key":"10.1002\/14651858.CD010610-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.4065\/81.10.1311","article-title":"Assessing the ability of topiramate to improve the daily activities of patients with migraine","volume":"81","author":"Brandes","year":"2006","journal-title":"Mayo Clinic Proceedings"},{"issue":"8","key":"10.1002\/14651858.CD010610-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1001\/jama.291.8.965","article-title":"Topiramate for migraine prevention: a randomized controlled trial","volume":"291","author":"Brandes","year":"2004","journal-title":"JAMA"},{"issue":"2","key":"10.1002\/14651858.CD010610-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.neulet.2008.06.076","article-title":"Effects of topiramate and levetiracetam vs placebo on habituation of contingent negative variation in migraine patients","volume":"442","author":"Tommaso","year":"2008","journal-title":"Neuroscience Letters"},{"issue":"10","key":"10.1002\/14651858.CD010610-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1016\/j.clinph.2007.06.060","article-title":"Effects of levetiracetam vs topiramate and placebo on visually evoked phase synchronization changes of alpha rhythm in migraine","volume":"118","author":"Tommaso","year":"2007","journal-title":"Clinical Neurophysiology"},{"issue":"8","key":"10.1002\/14651858.CD010610-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s00415-004-0464-6","article-title":"Topiramate in migraine prophylaxis: results from a placebo-controlled trial with propranolol as an active control","volume":"251","author":"Diener","year":"2004","journal-title":"Journal of Neurology"},{"issue":"12","key":"10.1002\/14651858.CD010610-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S1474-4422(07)70272-7","article-title":"Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial","volume":"6","author":"Diener","year":"2007","journal-title":"Lancet Neurology"},{"issue":"3","key":"10.1002\/14651858.CD010610-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.clinthera.2009.03.020","article-title":"Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs","volume":"31","author":"Dodick","year":"2009","journal-title":"Clinical Therapeutics"},{"issue":"4","key":"10.1002\/14651858.CD010610-BIB0010|cit10","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1046\/j.1468-2982.2000.00204.x","article-title":"Prophylactic treatment of episodic migraine with topiramate: a double-blind, placebo-controlled trial in 30 patients","volume":"20","author":"Edwards","year":"2000","journal-title":"Cephalalgia"},{"issue":"3","key":"10.1002\/14651858.CD010610-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1526-4610.2006.00599.x","article-title":"Low-dose topiramate versus lamotrigine in migraine prophylaxis (the Lotolamp study)","volume":"47","author":"Gupta","year":"2007","journal-title":"Headache"},{"issue":"1","key":"10.1002\/14651858.CD010610-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1177\/0333102410372427","article-title":"Topiramate intervention to prevent transformation of episodic migraine: the topiramate INTREPID study","volume":"31","author":"Lipton","year":"2011","journal-title":"Cephalalgia"},{"issue":"1","key":"10.1002\/14651858.CD010610-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1526-4637.2011.01295.x","article-title":"A randomized, one-year clinical trial comparing the efficacy of topiramate, flunarizine, and a combination of flunarizine and topiramate in migraine prophylaxis","volume":"13","author":"Luo","year":"2012","journal-title":"Pain Medicine"},{"issue":"5","key":"10.1002\/14651858.CD010610-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s10072-004-0350-0","article-title":"Topiramate in migraine prophylaxis: a randomised double-blind versus placebo study","volume":"25","author":"Mei","year":"2004","journal-title":"Neurological Sciences"},{"issue":"4","key":"10.1002\/14651858.CD010610-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/j.1526-4610.2006.00413.x","article-title":"Comparison of the effect of topiramate and sodium valproate in migraine prevention: a randomized blinded crossover study","volume":"46","author":"Shaygannejad","year":"2006","journal-title":"Headache"},{"issue":"6","key":"10.1002\/14651858.CD010610-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1185\/030079906X104731","article-title":"The impact of migraine on daily activities: effect of topiramate compared with placebo","volume":"22","author":"Silberstein","year":"2006","journal-title":"Current Medical Research & Opinion"},{"issue":"4","key":"10.1002\/14651858.CD010610-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/archneur.61.4.490","article-title":"Topiramate in migraine prevention: results of a large controlled trial","volume":"61","author":"Silberstein","year":"2004","journal-title":"Archives of Neurology"},{"issue":"7","key":"10.1002\/14651858.CD010610-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.clinthera.2006.07.003","article-title":"Efficacy and tolerability of topiramate 200 mg\/d in the prevention of migraine with\/without aura in adults: a randomized, placebo-controlled, double-blind, 12-week pilot study","volume":"28","author":"Silberstein","year":"2006","journal-title":"Clinical Therapeutics"},{"issue":"10","key":"10.1002\/14651858.CD010610-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1046\/j.1526-4610.2001.01190.x","article-title":"Topiramate in migraine prevention: a double-blind, placebo-controlled study","volume":"41","author":"Storey","year":"2001","journal-title":"Headache"},{"issue":"14","key":"10.1002\/14651858.CD010610-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1177\/0333102411419681","article-title":"Exercise as migraine prophylaxis: a randomized study using relaxation and topiramate as controls","volume":"31","author":"Varkey","year":"2011","journal-title":"Cephalalgia"},{"issue":"6","key":"10.1002\/14651858.CD010610-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/01.wnf.0000192136.46145.44","article-title":"Efficacy of topiramate and valproate in chronic migraine","volume":"28","author":"Bartolini","year":"2005","journal-title":"Clinical Neuropharmacology"},{"issue":"5","key":"10.1002\/14651858.CD010610-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"670","DOI":"10.3923\/ijp.2010.670.675","article-title":"Assessment of the middle dose of topiramate in comparison with sodium valproate for migraine prophylaxis: a randomized-double-blind study","volume":"6","author":"Bavrasad","year":"2010","journal-title":"International Journal of Pharmacology"},{"issue":"5","key":"10.1002\/14651858.CD010610-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1526-4610.2011.02054.x","article-title":"Two center, randomized pilot study of migraine prophylaxis comparing paradigms using pre-emptive frovatriptan or daily topiramate: research and clinical implications","volume":"52","author":"Cady","year":"2012","journal-title":"Headache"},{"issue":"6","key":"10.1002\/14651858.CD010610-BIB0024|cit24","first-page":"475","article-title":"Essay controlled by drawing, crossed, to evaluate the efficiency and safety of amitriptyline against topiramate in the prevention of the migraine","volume":"9","author":"Cazares","year":"2008","journal-title":"Revista Mexicana de Neurociencia"},{"key":"10.1002\/14651858.CD010610-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1046\/j.1526-4610.2001.01154-2.x","article-title":"Antiepileptic drugs: how they work in headache","volume":"41 Suppl 1","author":"Cutrer","year":"2001","journal-title":"Headache"},{"issue":"1-2","key":"10.1002\/14651858.CD010610-BIB0026|cit26","first-page":"164","article-title":"Topiramate as prophylactic treatment in migraine","volume":"38","author":"Trapani","year":"2000","journal-title":"Acta Medica Romana"},{"issue":"6","key":"10.1002\/14651858.CD010610-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1017\/S1092852900018733","article-title":"Topiramate in the preventive treatment of episodic migraine: a combined analysis from pilot, double-blind, placebo-controlled trials","volume":"8","author":"Edwards","year":"2003","journal-title":"CNS Spectrums"},{"issue":"6C","key":"10.1002\/14651858.CD010610-BIB0028|cit28","first-page":"S562","article-title":"Topiramate prophylaxis in patients suffering from migraine with aura: results from a randomized, double-blind, placebo-controlled trial","volume":"3","author":"Freitag","year":"2003","journal-title":"Advanced Studies in Medicine"},{"issue":"8","key":"10.1002\/14651858.CD010610-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/j.1468-2982.2007.01367.x","article-title":"Impact of preventive therapy with nadolol and topiramate on the quality of life of migraine patients","volume":"27","author":"Garcia-Monco","year":"2007","journal-title":"Cephalalgia"},{"issue":"1","key":"10.1002\/14651858.CD010610-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1526-4610.2009.01496.x","article-title":"Clinical assessment of topiramate therapy in patients with migrainous vertigo","volume":"50","author":"Gode","year":"2010","journal-title":"Headache"},{"key":"10.1002\/14651858.CD010610-BIB0031|cit31","first-page":"106","article-title":"Migraine prophylaxis with topiramate: results of double-blind, placebo-controlled, dose-response trials","volume":"44 Suppl 9","author":"Hart","year":"2003","journal-title":"Epilepsia"},{"issue":"8","key":"10.1002\/14651858.CD010610-BIB0032|cit32","first-page":"1563","article-title":"Topiramate (Topamax) for migraine prevention","volume":"72","author":"Huntington","year":"2005","journal-title":"American Family Physician"},{"issue":"10","key":"10.1002\/14651858.CD010610-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.clineuro.2008.05.025","article-title":"A double-blind randomized controlled trial of topiramate and amitriptyline either alone or in combination for the prevention of migraine","volume":"110","author":"Keskinbora","year":"2008","journal-title":"Clinical Neurology & Neurosurgery"},{"issue":"4","key":"10.1002\/14651858.CD010610-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/j.1526-4610.2011.01868.x","article-title":"Topiramate vs divalproex sodium in the preventive treatment of migraine: a prospective \"real-world\" study","volume":"51","author":"Krymchantowski","year":"2011","journal-title":"Headache"},{"issue":"1","key":"10.1002\/14651858.CD010610-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10194-011-0395-4","article-title":"Topiramate plus nortriptyline in the preventive treatment of migraine: a controlled study for nonresponders","volume":"13","author":"Krymchantowski","year":"2012","journal-title":"Journal of Headache & Pain"},{"issue":"5","key":"10.1002\/14651858.CD010610-BIB0036|cit36","first-page":"419","article-title":"A clinical study of sibelium combining topiramate in prophylactic treatment of migraine [original in Chinese]","volume":"19","author":"Li","year":"2002","journal-title":"Chinese Journal of Modern Applied Pharmacy"},{"issue":"4","key":"10.1002\/14651858.CD010610-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1526-4610.2007.00763_3.x","article-title":"Topiramate for migraine prophylaxis among Chinese population","volume":"47","author":"Li","year":"2007","journal-title":"Headache"},{"issue":"3","key":"10.1002\/14651858.CD010610-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/clpt.2008.203","article-title":"Are migraineurs at increased risk of adverse drug responses? A meta-analytic comparison of topiramate-related adverse drug reactions in epilepsy and migraine","volume":"85","author":"Luykx","year":"2009","journal-title":"Clinical Pharmacology & Therapeutics"},{"issue":"5","key":"10.1002\/14651858.CD010610-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000115637","article-title":"Subcutaneous histamine versus topiramate in migraine prophylaxis: a double-blind study","volume":"59","author":"Millan-Guerrero","year":"2008","journal-title":"European Neurology"},{"issue":"4","key":"10.1002\/14651858.CD010610-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/WNF.0b013e318225140c","article-title":"Zonisamide versus topiramate in migraine prophylaxis: a double-blind randomized clinical trial","volume":"34","author":"Mohammadianinejad","year":"2011","journal-title":"Clinical Neuropharmacology"},{"issue":"1","key":"10.1002\/14651858.CD010610-BIB0041|cit41","first-page":"17","article-title":"Topiramate in the prevention and treatment of migraine: efficacy, safety and patient preference","volume":"6","author":"Naegel","year":"2010","journal-title":"Neuropsychiatric Disease and Treatment"},{"issue":"5","key":"10.1002\/14651858.CD010610-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1468-2982.2009.01999.x","article-title":"Migraines with and without aura and their response to preventive therapy with topiramate","volume":"30","author":"Reuter","year":"2010","journal-title":"Cephalalgia"},{"issue":"5","key":"10.1002\/14651858.CD010610-BIB0043|cit43","first-page":"338","article-title":"Topiramate vs. amitriptyline in prophylactic treatment of migraine: a controlled clinical trial","volume":"11","author":"Rodr\u00edguez-Leyva","year":"2010","journal-title":"Revista Mexicana de Neurociencia"},{"key":"10.1002\/14651858.CD010610-BIB0044|cit44","first-page":"44","article-title":"Topiramate prophylaxis in patients suffering from migraine with aura: results from a randomized, double-blind placebo-controlled trial","volume":"9 Suppl 2","author":"Silberstein","year":"2002","journal-title":"European Journal of Neurology"},{"issue":"6C","key":"10.1002\/14651858.CD010610-BIB0045|cit45","first-page":"S565","article-title":"Efficacy and safety of topiramate in migraine prevention: a dose-ranging, placebo-controlled, double-blind, multicenter study","volume":"3","author":"Silberstein","year":"2003","journal-title":"Advanced Studies in Medicine"},{"issue":"8","key":"10.1002\/14651858.CD010610-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1046\/j.1468-2982.2003.00592.x","article-title":"Topiramate in the treatment of chronic migraine","volume":"23","author":"Silvestrini","year":"2003","journal-title":"Cephalalgia"},{"issue":"9","key":"10.1002\/14651858.CD010610-BIB0047|cit47","first-page":"717","article-title":"Classification of headache","volume":"179","author":"Ad Hoc Committee on the Classification of Headache of the National Institute of Neurological Diseases and Blindness","year":"1962","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD010610-BIB0048|cit48","unstructured":"Alderson P Green S Higgins JPT Highly sensitive search strategies for identifying reports of randomized controlled trials in MEDLINE. Cochrane Reviewers' Handbook 4.2.2 [updated December 2003]; Appendix 5b In: The Cochrane Library, Issue 1, 2004. Chichester, UK: John Wiley & Sons, Ltd"},{"issue":"1","key":"10.1002\/14651858.CD010610-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/oxfordjournals.qjmed.a030141","article-title":"Economic and social impact of migraine","volume":"89","author":"Clarke","year":"1996","journal-title":"QJM"},{"issue":"9","key":"10.1002\/14651858.CD010610-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.2174\/156802612800229215","article-title":"Recent progress in anticonvulsant drug research: strategies for anticonvulsant drug development and applications of antiepileptic drugs for non-epileptic central nervous system disorders","volume":"12","author":"Dalkara","year":"2012","journal-title":"Current Topics in Medicinal Chemistry"},{"issue":"2","key":"10.1002\/14651858.CD010610-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1017\/S0317167100047697","article-title":"Impact of migraine and tension-type headache on life-style, consulting behaviour, and medication use: a Canadian population survey","volume":"20","author":"Edmeads","year":"1993","journal-title":"Canadian Journal of Neurological Sciences"},{"issue":"9741","key":"10.1002\/14651858.CD010610-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0140-6736(10)60323-6","article-title":"New drugs in migraine treatment and prophylaxis: telcagepant and topiramate","volume":"376","author":"Edvinsson","year":"2010","journal-title":"Lancet"},{"issue":"9","key":"10.1002\/14651858.CD010610-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/j.1468-1331.2009.02748.x","article-title":"EFNS guideline on the drug treatment of migraine-revised report of an EFNS task force","volume":"16","author":"Evers","year":"2009","journal-title":"European Journal of Neurology"},{"issue":"9859","key":"10.1002\/14651858.CD010610-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/S0140-6736(12)61729-2","article-title":"Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Vos","year":"2013","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD010610-BIB0055|cit55","first-page":"1","article-title":"The International Classification of Headache Disorders: 2nd edition","volume":"24 Suppl 1","author":"Headache Classification Subcommittee of the International Headache Society","year":"2004","journal-title":"Cephalalgia"},{"key":"10.1002\/14651858.CD010610-BIB0056|cit56","first-page":"1","article-title":"Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain","volume":"8 Suppl 7","author":"Headache Classification Committee of the International Headache Society","year":"1988","journal-title":"Cephalalgia"},{"issue":"1","key":"10.1002\/14651858.CD010610-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD010610-BIB0058|cit58","unstructured":"Janssen-Cilag Topimax product information. LIF-the research based pharmaceutical industry; 2013 www.fass.se (accessed 15 March 2013)"},{"key":"10.1002\/14651858.CD010610-BIB0059|cit59","first-page":"307","article-title":"Relaxation treatment of recurrent headaches in children and adolescents","volume-title":"Headache and Migraine in Childhood and Adolescence","author":"Larsson","year":"2002"},{"issue":"5","key":"10.1002\/14651858.CD010610-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/j.1468-1331.2011.03612.x","article-title":"The cost of headache disorders in Europe: the Eurolight project","volume":"19","author":"Linde","year":"2012","journal-title":"European Journal of Neurology"},{"issue":"6","key":"10.1002\/14651858.CD010610-BIB0061|cit61","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010610","article-title":"Topiramate for the prophylaxis of episodic migraine in adults","author":"Linde","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD010610-BIB0062|cit62","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010611","article-title":"Valproate (valproic acid or sodium valproate or a combination of the two) for the prophylaxis of episodic migraine in adults","author":"Linde","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD010610-BIB0063|cit63","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010609","article-title":"Gabapentin or pregabalin for the prophylaxis of episodic migraine in adults","author":"Linde","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD010610-BIB0064|cit64","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010608","article-title":"Antiepileptics other than gabapentin, pregabalin, topiramate, and valproate for the prophylaxis of episodic migraine in adults","author":"Linde","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD010610-BIB0065|cit65","volume-title":"An Evidence-based Resource for Pain Relief","author":"McQuay","year":"1998"},{"issue":"8","key":"10.1002\/14651858.CD010610-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/j.1468-1331.2012.03681.x","article-title":"Self-medication of regular headache: a community pharmacy-based survey","volume":"19","author":"Mehuys","year":"2012","journal-title":"European Journal of Neurology"},{"issue":"6","key":"10.1002\/14651858.CD010610-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/j.1468-2982.2006.01172.x","article-title":"New appendix criteria open for a broader concept of chronic migraine","volume":"26","author":"Olesen","year":"2006","journal-title":"Cephalalgia"},{"key":"10.1002\/14651858.CD010610-BIB0068|cit68","first-page":"331","article-title":"Antiepileptic drugs","volume-title":"Basic and Clinical Pharmacology","author":"Porter","year":"1992"},{"issue":"7","key":"10.1002\/14651858.CD010610-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1212\/01.wnl.0000297551.27191.70","article-title":"Oxcarbazepine in migraine headache: a double-blind, randomized, placebo-controlled study","volume":"70","author":"Silberstein","year":"2008","journal-title":"Neurology"},{"issue":"17","key":"10.1002\/14651858.CD010610-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1212\/WNL.0b013e3182535d20","article-title":"Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society","volume":"78","author":"Silberstein","year":"2012","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD010610-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/0333102411417901","article-title":"Guidelines for controlled trials of drugs in migraine: third edition. A guide for investigators","volume":"32","author":"Tfelt-Hansen","year":"2012","journal-title":"Cephalalgia"},{"issue":"4","key":"10.1002\/14651858.CD010610-BIB0072|cit72","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002761","article-title":"Drugs for preventing migraine headaches in children","author":"Victor","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD010610-BIB0073|cit73","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001133.pub3","article-title":"Anticonvulsant drugs for acute and chronic pain","author":"Wiffen","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD010610-BIB0074|cit74","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003226.pub2","article-title":"Anticonvulsant drugs for migraine prophylaxis","author":"Chronicle","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD010610-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1468-2982.2008.01571.x","article-title":"Anticonvulsants in migraine prophylaxis: a Cochrane review","volume":"28","author":"Mulleners","year":"2008","journal-title":"Cephalalgia"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD010610\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T22:18:26Z","timestamp":1715552306000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD010610"}},"subtitle":[],"editor":[{"name":"Cochrane Pain, Palliative and Supportive Care Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,6,24]]},"references-count":75,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2016,5]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd010610","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,24]]}}}